Ingevity Corp (NGVT) Stock Forecast Oct. 16, 2026
Analysis updated on Oct. 16, 2026 (UTC) · Alpha · vs marketSwitch to Total · NYSE
Ingevity Corp (NGVT) stock forecast summary
On Oct. 16, 2026, NGVT is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 5171 stocks scored that day.
Ingevity Corp is a mid-cap company with a market capitalization of $2.40B. It ranks number 3 by market capitalization among the 17 Chemicals & Allied Products issuers in our coverage with a current forecast. Its P/B Ratio of 51.18x is the highest of the 12 peers that report one. Its ROE of 115.1% is the highest of the 10 peers that report one.
For NGVT, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 44.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 39.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.8%, buy ≥ +0.2%, sell < -0.9%, strong sell < -1.2% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, NGVT included.
Follow NGVT freeNGVT price chart and AI forecast
How NGVT ranks among 5171 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Ingevity Corp (NGVT) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Chemicals & Allied Products peers listed below that report each metric.
Valuation & Market
| Metric | NGVT | Rank |
|---|---|---|
| Market Cap | $2.40B | 3/17 |
| P/E Ratio | 33.73x | – |
| P/B Ratio | 51.18x | 1/12 |
| EPS | $2.07 | – |
| Book Value/Share | $1.36 | – |
| Revenue/Share | $31.72 | – |
| FCF/Share | $4.51 | – |
Profitability & Margins
| Metric | NGVT | Rank |
|---|---|---|
| ROE | 115.1% | 1/10 |
| ROA | 3.5% | 3/13 |
| ROIC | 59.2% | 1/12 |
| Gross Margin | 42.7% | 4/14 |
| Operating Margin | 65.2% | 1/13 |
| Net Margin | 5.0% | 3/12 |
| EBT Margin | 5.0% | 4/14 |
| Tax Rate | 28.9% | – |
Financial Health
| Metric | NGVT | Rank |
|---|---|---|
| Current Ratio | 1.61x | 11/16 |
| Quick Ratio | 1.15x | 8/13 |
| D/E Ratio | 31.78x | 1/13 |
| Financial Leverage | 32.78x | 1/14 |
| Interest Coverage | 15.2x | 3/14 |
| Working Capital | $206M | 7/16 |
Cash Flow
| Metric | NGVT | Rank |
|---|---|---|
| Operating Cash Flow | $211M | 5/15 |
| Free Cash Flow | $155M | 2/9 |
| Capital Spending | -$56M | 4/9 |
| OCF Growth YoY | -2.0% | 5/8 |
| FCF Growth YoY | 3.1% | 3/5 |
| FCF/Sales | 14.2% | 1/9 |
| CapEx/Sales | 5.1% | 3/9 |
Operational Efficiency
| Metric | NGVT | Rank |
|---|---|---|
| Asset Turnover | 0.71x | 5/13 |
| Inventory Turnover | 4.1x | 8/13 |
| Fixed Assets Turnover | 1.9x | 10/13 |
| Days Inventory | 90 days | 6/13 |
| Payables Period | 51 days | 8/10 |
Income Statement
| Metric | NGVT | Rank |
|---|---|---|
| Total Revenue | $1.09B | 6/13 |
| Operating Income | $711M | 1/14 |
| Net Income | $54M | 3/13 |
| R&D Expense | $26M | 5/10 |
| SG&A Expense | $164M | 6/13 |
| Cost of Goods Sold | $625M | 8/14 |
Dividend & Shareholder Information
| Metric | NGVT | Rank |
|---|---|---|
| Shares Outstanding | 34M | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $544M | 35.4% of assets |
| Cash & Short-term Investments | $97M | 6.3% of assets |
| Inventory | $154M | 10.0% of assets |
| Total Liabilities | $1.49B | 96.9% of assets |
| Short-term Debt | $250M | 16.2% of assets |
NGVT quarterly financials and insider trading
Ingevity Corp (NGVT) industry peers
Companies classified under the same SEC industry code as Ingevity Corp (Chemicals & Allied Products): 17 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| NGVT Ingevity Corp | ▶ | $2.40B |
| BCPC Balchem Corp | ▼ | $5.44B |
| PRM Perimeter Solutions, Inc. | ▶ | $4.34B |
| IOSP Innospec Inc. | ▼ | $2.38B |
| CC Chemours Co | ▶ | $1.92B |
| OLN Olin Corp | ▼ | $1.78B |
| HUN Huntsman Corp | ▼ | $1.49B |
| ECVT Ecovyst Inc. | ▶ | $1.13B |
| FMC Fmc Corp | ▲ | $709M |
| SLI Standard Lithium Ltd. | ▲ | $359M |
| ADUR Aduro Clean Technologies Inc. | ▼ | $332M |
| ACNT Ascent Industries Co. | ▼ | $122M |
| LQMT Liquidmetal Technologies Inc | ▶ | $78M |
| CITR Citrotech Inc. | ▶ | $68M |
| BLGO Biolargo, Inc. | ▲ | $24M |
| LOOP Loop Industries, Inc. | ▶ | $18M |
| GURE Gulf Resources, Inc. | ▲ | $5M |
Where NGVT sits on the market map
Ingevity Corp (NGVT) stock news
Loading...
Ingevity Corp (NGVT) stock forecast FAQ
What is the Ingevity Corp (NGVT) stock forecast?
On Oct. 16, 2026, NGVT is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 5171 stocks scored that day.
How accurate are Ingevity Corp stock predictions?
For NGVT, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 44.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 39.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Ingevity Corp forecasts updated?
Ingevity Corp forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.
Which companies are Ingevity Corp's industry peers?
17 issuers in our coverage, NGVT included, share the SEC industry code Chemicals & Allied Products. The largest are: Balchem Corp (BCPC), Perimeter Solutions, Inc. (PRM), Innospec Inc. (IOSP), Chemours Co (CC), Olin Corp (OLN), Huntsman Corp (HUN).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.